Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 918 blog entries.

August 2026

Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development

2026-08-18T08:44:11+00:00

Integration with Proscia’s Concentriq platform will facilitate pharma companies, diagnostic assay and platform providers, and CROs in operationalizing companion diagnostic programs Imagene AI, a leader in AI-powered precision oncology, today announced that it has joined the Proscia Ready partner alliance. Imagene AI is collaborating with Proscia® to integrate its advanced H&E tools and immunohistochemistry (IHC) [...]

Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development2026-08-18T08:44:11+00:00

Open-Source Platform Brings High-Resolution Spatial Biology Within Reach of Smaller Labs

2026-08-17T09:19:14+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  A new automated imaging platform developed at Georgia Institute of Technology and Emory University could make advanced spatial biology techniques accessible to laboratories that have limited resources. The imaging platform, called PRISMS (Python-based Robotic Imaging and Staining for Modular Spatial Omics), combines open-source software, affordable [...]

Open-Source Platform Brings High-Resolution Spatial Biology Within Reach of Smaller Labs2026-08-17T09:19:14+00:00

Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ

2026-08-14T06:48:56+00:00

The partnership brings elea’s pathology-specific AI directly into Techcyte Fusion, enabling pathologists to turn diagnostic assessments into structured, coded reports within their existing digital workflow, going beyond transcription while keeping the pathologist fully in control. Techcyte today announced the availability of eleaDNAi, elea’s AI-native pathology reporting technology, into Techcyte Fusion®, the digital pathology platform that brings [...]

Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ2026-08-14T06:48:56+00:00

Pathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy

2026-08-13T08:46:16+00:00

The following abstract is drawn from a recently published paper in Human Pathology | Journal | ScienceDirect.com by Elsevier. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Tristan Jordan, [...]

Pathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy2026-08-13T08:46:16+00:00

OnePath Diagnostic Now Runs on elea’s AI-Native Pathology Operating System

2026-08-27T12:13:53+00:00

The OnePath Diagnostics laboratory in Jacksonville, Florida, is now running on elea's AI-native Pathology Operating System, the result of a partnership built station by station, long before the first case moved through the system. In practice, the lab side of the case is now orchestrated in one place: accessioning, grossing, specimen tracking, and the handoffs in [...]

OnePath Diagnostic Now Runs on elea’s AI-Native Pathology Operating System2026-08-27T12:13:53+00:00

A multisite survey on patient perspectives of breast cancer risk assessment and supplemental breast cancer screening tools

2026-08-12T08:47:23+00:00

The following abstract is drawn from a recently published paper in Clinical Imaging. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Liliana Lighta, Miguel Penab, Sarah M. Pittmanb, Tie [...]

A multisite survey on patient perspectives of breast cancer risk assessment and supplemental breast cancer screening tools2026-08-12T08:47:23+00:00

Keeping Digital Pathology Open: The Regulatory Framework Behind Concentriq AP-Dx

2026-08-10T07:51:40+00:00

By Ian Cadieux, Head of Quality and Regulatory Interoperability in digital pathology is about more than the ability to open an image file. It means giving pathologists a consistent, trusted experience as laboratories add scanners, displays, and connected systems. Selecting a digital pathology platform for primary diagnosis is a long-term, important decision [...]

Keeping Digital Pathology Open: The Regulatory Framework Behind Concentriq AP-Dx2026-08-10T07:51:40+00:00

Lumea Climbs the 2026 Inc. 5000 Ranking, Reflecting Continued Rapid Growth

2026-08-11T14:54:03+00:00

Company Recognized for Large Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses By Bianca Collings Lumea today announced it has been ranked No. 1,641 on the 2026 Inc. 5000 list, the annual list of the fastest-growing private companies in America. Lumea also ranked No. 38 among Utah companies [...]

Lumea Climbs the 2026 Inc. 5000 Ranking, Reflecting Continued Rapid Growth2026-08-11T14:54:03+00:00

Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software

2026-09-29T14:21:05+00:00

Portfolio expansion marks new era for diagnosis delivery, translating digital pathology innovation to clinical impact by accelerating workflows and patient care Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today announced multiple U.S. Food and Drug Administration (FDA) 510(k) clearances that strengthen its connected clinical digital pathology [...]

Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software2026-09-29T14:21:05+00:00

NPIC Summit 2026: Steering the Global Future of Digital Pathology

2026-09-01T08:13:25+00:00

Author: Sidney Ocanagil-Tunstall, Editorial Lead & Marketing Director at Pathology News A Window into the Future of UK Healthcare The UK healthcare system currently stands at an inflection point. Interpreting and juggling the demands of the NHS 10-year plan, absorbing the stark realities presented in the Darzi report, and closer to home for our audience: [...]

NPIC Summit 2026: Steering the Global Future of Digital Pathology2026-09-01T08:13:25+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

Š Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top